This inventor holds 1 USPTO granted patent. Top assignees: Gunma University, Kumamoto University, Transgenic Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2020
Title: Daisuke Oikawa: Innovator in Inflammatory Reaction Detection
Introduction
Daisuke Oikawa is a notable inventor based in Gunma, Japan. He has made significant contributions to the field of biomedical research, particularly in the detection of inflammatory reactions. His innovative approach has led to the development of a unique patent that enhances our understanding of inflammation.
Latest Patents
Daisuke Oikawa holds a patent for an "Inflammation Reporter System." This invention provides a method for detecting inflammatory reactions by utilizing a transformant or transgenic non-human animal. The system involves transfecting a vector that includes a promoter for a gene encoding an inflammatory cytokine, a gene encoding a reporter protein, and a gene encoding a proteolytic signal sequence. This method allows for the detection of inflammatory reactions induced by inflammatory stimulation in the transformant or transgenic non-human animal.
Career Highlights
Throughout his career, Daisuke Oikawa has worked with prominent organizations such as Transgenic Inc. and Gunma University. His work in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Daisuke has collaborated with notable colleagues, including Kenichi Yamamura and Takao Iwawaki. These partnerships have further enriched his research and innovation in the field of inflammation detection.
Conclusion
Daisuke Oikawa's contributions to the detection of inflammatory reactions through his patented invention highlight his role as an influential inventor in the biomedical field. His work continues to pave the way for advancements in understanding inflammation and its implications in health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile